Intravitreal Aflibercept Injection (IAI) for Radiation Retinopathy Trial (ARRT)
Latest Information Update: 26 Jul 2023
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic retinopathy; Retinal disorders; Retinal oedema
- Focus Adverse reactions; Therapeutic Use
- Acronyms ARRT
- 01 Jun 2023 Primary endpoint has not been met (mean Early Treatment Diabetic Retinopathy Study best-corrected visual acuity (BCVA) change from baseline) , according to Results published in the Investigative Ophthalmology and Visual Science
- 01 Jun 2023 Results published in the Investigative Ophthalmology and Visual Science
- 07 Dec 2020 Status changed from recruiting to active, no longer recruiting.